• Citer

Phase II study of vinorelbine in patients with androgen-independent prostate cancer.

par Oudard, S;Caty, A;Humblet, Yves;Beauduin, Marc;Suc, E;Piccart-Gebhart, Martine ;Rolland, Frédéric ;Fumoleau, Pierre;Bugat, Roland;Houyau, P;Monnier, A;Sun, X;Montcuquet, P;Breza, J;Novak, J;Gil, Thierry ;Chopin, D
Référence Annals of oncology, 12, 6, page (847-852)
Publication Publié, 2001-06

Article révisé par les pairs

• Détails
• Contenu

Titre:	Phase II study of vinorelbine in patients with androgen-independent prostate cancer.
Auteur:	Oudard, S; Caty, A; Humblet, Yves; Beauduin, Marc; Suc, E; Piccart-Gebhart, Martine; Rolland, Frédéric; Fumoleau, Pierre; Bugat, Roland; Houyau, P; Monnier, A; Sun, X; Montcuquet, P; Breza, J; Novak, J; Gil, Thierry; Chopin, D
Informations sur la publication:	Annals of oncology, 12, 6, page (847-852)
Statut de publication:	Publié, 2001-06
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adenocarcinoma -- drug therapy
	Adenocarcinoma -- pathology
	Aged
	Aged, 80 and over
	Androgens -- metabolism
	Antineoplastic Agents, Phytogenic -- administration & dosage
	Antineoplastic Agents, Phytogenic -- therapeutic use
	Antineoplastic Agents, Phytogenic -- toxicity
	Disease-Free Survival
	Drug Administration Schedule
	Humans
	Leukopenia -- chemically induced
	Male
	Middle Aged
	Neoplasm Metastasis
	Neutropenia -- chemically induced
	Pain Measurement
	Prostate-Specific Antigen -- blood
	Prostatic Neoplasms -- drug therapy
	Prostatic Neoplasms -- pathology
	Quality of Life
	Vinblastine -- administration & dosage
	Vinblastine -- adverse effects
	Vinblastine -- analogs & derivatives
	Vinblastine -- therapeutic use
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Comparative Study
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:pmid/11484963